THEA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
THEA PHARMA
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€1.0m
2024 · €965,749+€58,885
Equity
€8.8m
2024 · €8.7m+€24,635
Cash
€492,044
2024 · €1.9m-€1.4m
Balance sheet total
€16.7m
2024 · €14.1m+€2.6m
Largest movements
Assets
- Receivables within one year +€2.2m
up €2.2m (+59.4%), from €3.8m to €6.0m
of which Trade receivables: +€2.7m
- Stocks and contracts +€2.0m
up €2.0m (+26.1%), from €7.7m to €9.8m
- Cash -€1.4m
down €1.4m (-74.3%), from €1.9m to €492,044
mainly Receivables within one year (-€2.2m) and Stocks and contracts (-€2.0m)
- Deferred charges and accrued income -€221,230
down €221,230 (-59.8%), from €369,957 to €148,727
Equity and liabilities
- Trade debts +€2.7m
up €2.7m (+81.6%), from €3.3m to €6.0m
Income statement
- Turnover +€1.8m
up €1.8m (+6.3%), from €28.2m to €30.0m
- Goods and materials +€1.6m
up €1.6m (+8.3%), from €19.1m to €20.7m
of which Purchases: +€2.8m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€965,749
Turnover
+€1.8m
Other operating income
+€49,725
Goods and materials
-€1.6m
Services and other goods
+€299,258
Staff costs
-€265,311
Depreciation
-€5,051
Write-downs
+€13,253
Other operating charges
-€221,376
Financial income
+€6,045
Financial charges
-€3,787
Taxes
-€10,966
Result 2025
€1.0m
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€405,439
Investment
-€16,071
Financing
-€1.0m
Cash 2024
€1.9m
From operations (derived)
-€405,439
Net result for the year
+€1.0m
Depreciation
+€43,487
Stocks and contracts
-€2.0m
Receivables within one year
-€2.2m
Deferred charges and accrued income
+€221,230
Trade debts
+€2.7m
Tax, wage and social debts
-€124,856
Investment (derived)
-€16,071
Investment in fixed assets (net)
-€16,071
Financing
-€1.0m
Contributions, distributions and other
-€1.0m
Cash 2025
€492,044
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €14,068,542 | €16,662,530 | +€2.6m | +18.4% |
| Fixed assets | 21/28 | €264,393 | €236,976 | -€27,416 | -10.4% |
| Tangible fixed assets | 22/27 | €208,018 | €180,887 | -€27,131 | -13.0% |
| Plant, machinery and equipment | 23 | €576 | €3,713 | +€3,137 | +545% |
| Furniture and vehicles | 24 | €47,720 | €37,226 | -€10,494 | -22.0% |
| Other tangible fixed assets | 26 | €159,722 | €139,948 | -€19,774 | -12.4% |
| Financial fixed assets | 28 | €56,375 | €56,089 | -€285 | -0.5% |
| Other financial fixed assets | 284/8 | €56,375 | €56,089 | -€285 | -0.5% |
| Amounts receivable and cash guarantees | 285/8 | €56,375 | €56,089 | -€285 | -0.5% |
| Current assets | 29/58 | €13,804,149 | €16,425,554 | +€2.6m | +19.0% |
| Stocks and contracts in progress | 3 | €7,743,430 | €9,764,501 | +€2.0m | +26.1% |
| Stocks | 30/36 | €7,743,430 | €9,764,501 | +€2.0m | +26.1% |
| Goods purchased for resale | 34 | €7,743,430 | €9,764,501 | +€2.0m | +26.1% |
| Amounts receivable within one year | 40/41 | €3,777,208 | €6,020,281 | +€2.2m | +59.4% |
| Trade receivables | 40 | €3,345,213 | €6,016,971 | +€2.7m | +79.9% |
| Other amounts receivable | 41 | €431,995 | €3,310 | -€428,685 | -99.2% |
| Cash at bank and in hand | 54/58 | €1,913,554 | €492,044 | -€1.4m | -74.3% |
| Deferred charges and accrued income | 490/1 | €369,957 | €148,727 | -€221,230 | -59.8% |
| Total equity and liabilities | 10/49 | €14,068,542 | €16,662,530 | +€2.6m | +18.4% |
| Equity | 10/15 | €8,735,648 | €8,760,283 | +€24,635 | +0.3% |
| Contributions | 10/11 | €1,050,000 | €1,050,000 | = | 0.0% |
| Capital | 10 | €1,050,000 | €1,050,000 | = | 0.0% |
| Issued capital | 100 | €1,050,000 | €1,050,000 | = | 0.0% |
| Reserves | 13 | €7,685,648 | €7,710,000 | +€24,352 | +0.3% |
| Non-distributable reserves | 130/1 | €105,000 | €105,000 | = | 0.0% |
| Legal reserve | 130 | €105,000 | €105,000 | = | 0.0% |
| Distributable reserves | 133 | €7,580,648 | €7,605,000 | +€24,352 | +0.3% |
| Profit (loss) carried forward | 14 | - | €283 | +€283 | |
| Amounts payable | 17/49 | €5,332,894 | €7,902,247 | +€2.6m | +48.2% |
| Amounts payable within one year | 42/48 | €5,332,894 | €7,902,247 | +€2.6m | +48.2% |
| Trade debts | 44 | €3,302,287 | €5,996,497 | +€2.7m | +81.6% |
| Suppliers | 440/4 | €3,302,287 | €5,996,497 | +€2.7m | +81.6% |
| Taxes, remuneration and social security | 45 | €1,030,607 | €905,751 | -€124,856 | -12.1% |
| Taxes | 450/3 | €350,443 | €214,996 | -€135,448 | -38.7% |
| Remuneration and social security | 454/9 | €680,164 | €690,755 | +€10,591 | +1.6% |
| Other amounts payable | 47/48 | €1,000,000 | €1,000,000 | = | 0.0% |
| Operating income | 70/76A | €28,458,147 | €30,294,464 | +€1.8m | +6.5% |
| Turnover | 70 | €28,199,771 | €29,986,363 | +€1.8m | +6.3% |
| Other operating income | 74 | €258,376 | €308,101 | +€49,725 | +19.2% |
| Operating charges | 60/66A | €27,089,365 | €28,858,090 | +€1.8m | +6.5% |
| Goods for resale, raw materials and consumables | 60 | €19,118,594 | €20,708,092 | +€1.6m | +8.3% |
| Purchases | 600/8 | €19,939,338 | €22,756,357 | +€2.8m | +14.1% |
| Change in stocks: decrease (increase) | 609 | -€820,744 | -€2,048,265 | -€1.2m | -150% |
| Services and other goods | 61 | €3,665,682 | €3,366,424 | -€299,258 | -8.2% |
| Remuneration, social security and pensions | 62 | €3,352,711 | €3,618,023 | +€265,311 | +7.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38,436 | €43,487 | +€5,051 | +13.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €45,766 | €32,512 | -€13,253 | -29.0% |
| Other operating charges | 640/8 | €868,177 | €1,089,553 | +€221,376 | +25.5% |
| Operating profit (loss) | 9901 | €1,368,781 | €1,436,374 | +€67,593 | +4.9% |
| Financial income | 75/76B | €2,229 | €8,274 | +€6,045 | +271% |
| Recurring financial income | 75 | €2,229 | €8,274 | +€6,045 | +271% |
| Other financial income | 752/9 | €2,229 | €8,274 | +€6,045 | +271% |
| Financial charges | 65/66B | €19,537 | €23,324 | +€3,787 | +19.4% |
| Recurring financial charges | 65 | €19,537 | €23,324 | +€3,787 | +19.4% |
| Debt charges | 650 | €15,621 | €18,827 | +€3,206 | +20.5% |
| Other financial charges | 652/9 | €3,916 | €4,497 | +€581 | +14.8% |
| Profit (loss) for the period before taxes | 9903 | €1,351,474 | €1,421,325 | +€69,851 | +5.2% |
| Income taxes | 67/77 | €385,724 | €396,690 | +€10,966 | +2.8% |
| Taxes | 670/3 | €385,724 | €396,690 | +€10,966 | +2.8% |
| Profit (loss) for the period | 9904 | €965,749 | €1,024,635 | +€58,885 | +6.1% |
| Profit (loss) for the period to be appropriated | 9905 | €965,749 | €1,024,635 | +€58,885 | +6.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.